MX9204212A - Preparado de combinacion farmaceutico. - Google Patents

Preparado de combinacion farmaceutico.

Info

Publication number
MX9204212A
MX9204212A MX9204212A MX9204212A MX9204212A MX 9204212 A MX9204212 A MX 9204212A MX 9204212 A MX9204212 A MX 9204212A MX 9204212 A MX9204212 A MX 9204212A MX 9204212 A MX9204212 A MX 9204212A
Authority
MX
Mexico
Prior art keywords
atoms
phenyl
alkyl
radical
halogen
Prior art date
Application number
MX9204212A
Other languages
English (en)
Inventor
Jean-Paul Clozel
Rita Muller
Wolfgang Osterrieder
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9204212A publication Critical patent/MX9204212A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Preparación de combinación antihipertensiva que contiene un derivado de tetrahidronaftaleno de la fórmula general (I): (fórmula); y una piridazodiacepina de la fórmula general: (fórmula II); en forma de sus bases libres, sus hidratos o sus sales farmacéuticamente utilizables para el uso simultanéo, separado o planificado escalonadamente.
MX9204212A 1991-07-23 1992-07-17 Preparado de combinacion farmaceutico. MX9204212A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH219191 1991-07-23

Publications (1)

Publication Number Publication Date
MX9204212A true MX9204212A (es) 1993-08-01

Family

ID=4228024

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204212A MX9204212A (es) 1991-07-23 1992-07-17 Preparado de combinacion farmaceutico.

Country Status (31)

Country Link
US (1) US5620975A (es)
EP (1) EP0524512B1 (es)
JP (1) JPH0680009B2 (es)
KR (1) KR100260479B1 (es)
CN (1) CN1040505C (es)
AT (1) ATE260661T1 (es)
AU (1) AU656207B2 (es)
BG (1) BG60949B1 (es)
BR (1) BR9202830A (es)
CA (1) CA2074039C (es)
CZ (1) CZ281691B6 (es)
DE (1) DE59209993D1 (es)
DK (1) DK0524512T3 (es)
ES (1) ES2215160T3 (es)
HR (1) HRP930953B1 (es)
HU (1) HU214029B (es)
IE (1) IE922378A1 (es)
IL (1) IL102541A (es)
IS (1) IS3887A (es)
MX (1) MX9204212A (es)
MY (1) MY118064A (es)
NO (1) NO301047B1 (es)
NZ (1) NZ243577A (es)
PT (1) PT524512E (es)
RO (1) RO110905B (es)
RU (1) RU2084225C1 (es)
SK (1) SK278918B6 (es)
TW (1) TW216770B (es)
UY (1) UY23449A1 (es)
YU (2) YU49198B (es)
ZA (1) ZA925322B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0634175B1 (de) * 1993-07-15 2001-01-10 F. Hoffmann-La Roche Ag Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält
IL131816A (en) 1997-04-04 2003-06-24 Exxon Res & Engineering Compan Composite structures having high containment strength
EP1438297A1 (en) 2001-10-10 2004-07-21 Aryx Therapeutics Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
US7687086B1 (en) 2003-02-28 2010-03-30 University Of Portland Method for obtaining taxanes
EP2537534B1 (en) 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
DK171349B1 (da) * 1986-11-14 1996-09-16 Hoffmann La Roche Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf, lægemidler indeholdende forbindelserne samt anvendelse af forbindelserne til fremstilling af lægemidler
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
US5110813A (en) * 1987-09-15 1992-05-05 Alcoholism And Drug Addiction Research Foundation Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
KR940005408B1 (ko) * 1990-12-03 1994-06-18 만도기계 주식회사 파워 윈도우 모우터 회전자의 선단부 흔들림 측정장치

Also Published As

Publication number Publication date
HUT62792A (en) 1993-06-28
ES2215160T3 (es) 2004-10-01
YU49198B (sh) 2004-09-03
JPH0680009B2 (ja) 1994-10-12
EP0524512B1 (de) 2004-03-03
BG60949B1 (bg) 1996-07-31
SK227092A3 (en) 1996-02-07
IS3887A (is) 1993-01-24
HU9202367D0 (en) 1992-10-28
CN1040505C (zh) 1998-11-04
UY23449A1 (es) 1993-01-21
ATE260661T1 (de) 2004-03-15
EP0524512A2 (de) 1993-01-27
YU72392A (sh) 1997-05-28
NO922903L (no) 1993-01-25
TW216770B (es) 1993-12-01
AU656207B2 (en) 1995-01-27
CZ281691B6 (cs) 1996-12-11
DE59209993D1 (de) 2004-04-08
CZ227092A3 (en) 1993-02-17
HRP930953B1 (en) 2003-06-30
MY118064A (en) 2004-08-30
JPH05194217A (ja) 1993-08-03
NO301047B1 (no) 1997-09-08
CN1068737A (zh) 1993-02-10
PT524512E (pt) 2004-07-30
RO110905B (ro) 1996-05-30
KR930001910A (ko) 1993-02-22
AU2041692A (en) 1993-01-28
IL102541A (en) 1995-12-08
CA2074039A1 (en) 1993-01-24
RU2084225C1 (ru) 1997-07-20
SK278918B6 (sk) 1998-04-08
IL102541A0 (en) 1993-01-14
EP0524512A3 (en) 1993-09-01
HRP930953A2 (en) 1995-10-31
IE922378A1 (en) 1993-01-27
ZA925322B (en) 1993-03-31
NO922903D0 (no) 1992-07-22
DK0524512T3 (da) 2004-07-05
CA2074039C (en) 2004-11-02
BR9202830A (pt) 1993-03-23
HU214029B (en) 1997-12-29
US5620975A (en) 1997-04-15
KR100260479B1 (ko) 2000-07-01
NZ243577A (en) 1994-09-27

Similar Documents

Publication Publication Date Title
NL300034I2 (nl) Gesubstitueerde thiahzolidinedionderivaten.
KR950003276A (ko) 당단백질 IIb/IIIa 길항물질
KR930703319A (ko) 키산틴 유도체
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
MX9204212A (es) Preparado de combinacion farmaceutico.
MX9633A (es) Procedimiento para la preparacion de nuevos productos esteroides que llevan en la posicion 23 un radical sulfinilo y producto obtenido.
NZ221004A (en) 2,6-piperazinediones and pharamceutical compositions
AU3626189A (en) New derivatives of phenothiazine, their preparation and the compositions which contain them
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
IL59358A0 (en) Thiazole derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG Grant or registration
GD Licence granted